Carbon monoxide poisoning

When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Última revisión: 24 Sep 2025
Última actualización: 19 Dec 2024

Resumen

Definition

History and exam

Key diagnostic factors

  • exposure to incomplete combustion of carbon-containing material
  • exposure to fire with smoke inhalation
  • nausea
  • headache
  • vomiting
  • blurred vision
  • dizziness
  • vertigo
  • altered consciousness
  • dyspnea
  • tachycardia
  • hypotension or hypertension
  • cardiac arrhythmias
  • pain
  • weakness
  • sleep changes
  • irritability
  • flu-like symptoms
Full details

Other diagnostic factors

  • exposure to methylene chloride
  • delayed neuropsychiatric features
  • other severe neurologic symptoms
  • cutaneous blistering
  • pulmonary edema
  • cardiac arrest
  • focal neurologic abnormalities (e.g., hemiplegia, truncal ataxia)
  • disseminated intravascular coagulation
Full details

Risk factors

  • exposure to incomplete combustion of carbon-containing material
  • exposure to fire with smoke inhalation
  • exposure to methylene chloride
Full details

Diagnostic tests

1st tests to order

  • carboxyhemoglobin level
  • ECG
  • cardiac monitoring
  • blood glucose
  • complete blood count
  • urea and electrolytes
  • creatinine
  • lactate
  • pH level
  • cardiac biomarkers
  • creatine kinase
Full details

Tests to consider

  • chest x-ray
  • Mini Mental State Examination
  • CT head
  • magnetic resonance imaging and spectroscopy
  • liver function tests
  • pregnancy test
Full details

Treatment algorithm

ACUTE

all patients

Contributors

Expert advisers

Richard Moon, MD

Professor of Anesthesiology

Professor of Medicine

Division of Pulmonary, Allergy and Critical Care Medicine

Duke University

Durham

NC

Disclosures

RM has been reimbursed by Merck for contributions to the Merck Manual.

Acknowledgements

Dr. Richard Moon would like to gratefully acknowledge Dr Jason Rose and Dr Prasanthi Govindarajan, previous contributors to this topic.

Disclosures

PG declares that she has no competing interests. JR is a co-inventor on patent applications for the use of heme-based molecules as antidotes for CO poisoning. JR is a shareholder, officer, and director of Globin Solutions, Inc. Globin Solutions, Inc. has an exclusive license to this technology. Globin Solutions, Inc. had an option agreement to technology directed at using hydroxycobalamin for CO poisoning from Virginia Commonwealth University in the last 12 months. JR is an author of publications cited within this topic.

Peer reviewers

Richard S. Weisman, PharmD

Director

Florida Poison Center

Miami

FL

Disclosures

RSW declares that he has no competing interests.

Sean Patrick Nordt, MD, PharmD

Resident Physician

Department of Emergency Medicine

University of California

San Diego

CA

Disclosures

SPN declares that he has no competing interests.

Paul Hamilton, MD

Director

Department of Emergency Medicine

Mount Sinai School of Medicine

New York

NY

Divulgaciones

PH declares that he has no competing interests.

Ruben Thanacoody, MD, FRCP(Edin)

Consultant Physician and Clinical Toxicologist

Regional Drugs and Therapeutics Centre

Newcastle-upon-Tyne

UK

Divulgaciones

RT declares that he has no competing interests.

Agradecimiento de los revisores por pares

Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.

Divulgaciones

Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Hampson NB, Piantadosi CA, Thom SR, et al. Practice recommendations in the diagnosis, management, and prevention of carbon monoxide poisoning. Am J Respir Crit Care Med. 2012 Dec 1;186(11):1095-101.Texto completo  Resumen

Centers for Disease Control and Prevention. Clinical guidance for carbon monoxide poisoning following disasters and severe weather. Jul 2024 [internet publication].Texto completo

Wolf SJ, Maloney GE, Shih RD, et al; American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Carbon Monoxide Poisoning. Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with acute carbon monoxide poisoning. Ann Emerg Med. 2017 Jan;69(1):98-107.e6.Texto completo  Resumen

Weaver LK. Carbon monoxide poisoning. Undersea Hyperb Med. 2020 First Quarter;47(1):151-69.Texto completo  Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
  • Diferenciales

    • Viral infection
    • Alcohol intoxication
    • Migraine
    Más Diferenciales
  • Guías de práctica clínica

    • Clinical guidance for carbon monoxide poisoning following disasters and severe weather
    • Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with acute carbon monoxide poisoning
    Más Guías de práctica clínica
  • Folletos para el paciente

    Carbon monoxide poisoning

    Más Folletos para el paciente
  • padlock-lockedInicie sesión o suscríbase para acceder a todo el BMJ Best Practice

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad